Significance: The shortwave infrared (SWIR) optical window (∼900 to 2000 nm) has attracted interest for deep tissue imaging due to the lower scattering of light. SWIR spatial frequency domain imaging (SWIR SFDI) provides wide-field tissue optical property measurements in this wavelength band. Key design and performance characteristics, such as portability, wavelength selection, measurement resolution, and the effect of skin have not yet been addressed for SWIR SFDI. Aim: To fabricate and characterize a SWIR SFDI system for clinical use. Approach: The optimal choice of wavelengths was identified based on optical property uncertainty estimates and imaging depth. A compact light-emitting diode-based dual wavelength SWIR SFDI system was fabricated. A two-layer inverse model was developed to account for the layered structure of skin. Performance was validated using tissue-simulating phantoms and in-vivo measurements from three healthy subjects. Results: The SWIR SFDI system had a μs′ resolution of at least 0.03 mm − 1 at 880 nm and 0.02 mm − 1 at 1100 nm. The two-layer inverse model reduced the error in deeper layer μs′ extractions by at least 24% in the phantom study. The two-layer model also increased the contrast between superficial vessels and the surrounding tissue for in-vivo measurements. Conclusion: The clinic-ready SWIR SFDI device is sensitive to small optical property alterations in diffuse media, provides enhanced accuracy in quantifying optical properties in the deeper layers in phantoms, and provided enhanced contrast of subcutaneous blood vessels.
The shortwave infrared (SWIR) wavelength band (1,000–2,000 nm) has recently garnered increased interest due to its beneficial attributes for tissue imaging and spectroscopy. Lower scattering, increased sensitivity to endogenous water and lipid content, and the reduced influence of melanin offer new measurement opportunities and application areas. SWIR sensor technology is advancing at a rapid pace, fueling growth in academic and commercial instrument development. Here, we review recent progress in SWIR tissue imaging and spectroscopy, provide resources on tissue optical properties at SWIR wavelengths, and offer guidance on the utilization of models, methods, and instruments for SWIR measurements in tissue. One key finding is that while some efforts have exploited the lower scattering in the SWIR to achieve deep tissue imaging, this advantage is highly dependent on the specific choice of wavelength and the measurement geometry. Photon attenuation limits these advantages at wavelengths where water absorption is strong, especially in the context of higher-noise SWIR detectors. However, a growing number of clinical applications are emerging, especially those requiring in vivo water and lipid measurements, such as monitoring of tissue hydration, edema, lipid content, and others. There are further opportunities to expand this work toward more disease states while leveraging the low absorption of melanin in the SWIR. Since the field is currently limited by relatively few sources of tissue optical property data at SWIR wavelengths, we have compiled tabulated extinction values of SWIR chromophores from the literature. There is also a need for continued development of techniques for modeling photon propagation in tissue at SWIR wavelengths due to more moderate levels of tissue scattering compared to absorption, and methods to establish stable tissue-mimicking phantoms. The SWIR wavelength region is coming of age in the biophotonics community, with components and systems creating new opportunities in basic research and clinical applications once current challenges can be overcome.
Systemic sclerosis (SSc) is an autoimmune disease characterized by the widespread deposition of excess collagen in the skin and internal organs, as well as vascular dysfunction. The current standard of care technique used to quantify the extent of skin fibrosis in SSc patients is the modified Rodnan skin score (mRSS), which is an assessment of skin thickness based on clinical palpation. Despite being considered the gold standard, mRSS testing requires a trained physician and suffers from high inter-observer variability. In this study, we evaluated the use of spatial frequency domain imaging (SFDI) as a more quantitative and reliable method for assessing skin fibrosis in SSc patients. SFDI is a wide-field and non-contact imaging technique that utilizes spatially modulated light to generate a map of optical properties in biological tissue. The SFDI data were collected at six measurement sites (left and right forearms, hands, and fingers) of eight control subjects and ten SSc patients. mRSS were assessed by a physician, and skin biopsies were collected from subject’s forearms and used to assess for markers of skin fibrosis. Our results indicate that SFDI is sensitive to skin changes even at an early stage, as we found a significant difference in the measured optical scattering (μs′) between healthy controls and SSc patients with a local mRSS score of zero (no appreciable skin fibrosis by gold standard). Furthermore, we found a strong correlation between the diffuse reflectance (Rd) at a spatial frequency of 0.2 mm−1 and the total mRSS between all subjects (Spearman correlation coefficient = -0.73, p-value < 0.0028), as well as high correlation with histology results. The healthy volunteer results show excellent inter- and intra-observer reliability (ICC > 0.8). Our results suggest that the measurement of tissue μs′ and Rd at specific spatial frequencies and wavelengths can provide an objective and quantitative assessment of skin involvement in SSc patients, which could greatly improve the accuracy and efficiency of monitoring disease progression and evaluating drug efficacy.
SignificanceThe shortwave infrared (SWIR, ∼900 to 2000 nm) holds promise for label-free measurements of water and lipid content in thick tissue, owed to the chromophore-specific absorption features and low scattering in this range. In vivo water and lipid estimations have potential applications including the monitoring of hydration, volume status, edema, body composition, weight loss, and cancer. To the best of our knowledge, there are currently no point-of-care or wearable devices available that exploit the SWIR wavelength range, limiting clinical and at-home translation of this technology.AimTo design and fabricate a diffuse optical wearable SWIR probe for water and lipid quantification in tissue.ApproachSimulations were first performed to confirm the theoretical advantage of SWIR wavelengths over near infrared (NIR). The probe was then fabricated, consisting of light emitting diodes at three wavelengths (980, 1200, 1300 nm) and four source-detector (S-D) separations (7, 10, 13, 16 mm). In vitro validation was then performed on emulsion phantoms containing varying concentrations of water, lipid, and deuterium oxide (D2O). A deep neural network was developed as the inverse model for quantity estimation.ResultsSimulations indicated that SWIR wavelengths could reduce theoretical water and lipid extraction errors from ∼6 % to ∼1 % when compared to NIR wavelengths. The SWIR probe had good signal-to-noise ratio (>32 dB up to 10 mm S-D) and low drift (<1.1 % up to 10 mm S-D). Quantification error in emulsion phantoms was 2.1 ± 1.1 % for water and −1.2 ± 1.5 % for lipid. Water estimation during a D2O dilution experiment had an error of 3.1 ± 3.7 % .ConclusionsThis diffuse optical SWIR probe was able to quantify water and lipid contents in vitro with good accuracy, opening the door to human investigations.
Plasma lipoproteins, which are complex biochemical particles that transport hydrophobic lipids through the blood, are largely unrecognized as a potential optical biomarker for the evaluation of cardiovascular health. Lipoprotein particles are known to be partially responsible for blood plasma turbidity, and they very likely affect blood optical properties. Plasma levels of triglyceride (TG) and cholesterol, which are packaged and transported in blood within lipoproteins, are strongly predictive of future cardiovascular events, including heart attack and stroke.1,2 Currently, measurement of these plasma blood lipids requires invasive blood draw and traditional laboratory-based testing. Label-free optical measurements of blood lipoproteins may have important implications for cardiovascular health assessment, especially for those suffering from dyslipidemias, such as type 2 diabetes.3
SignificanceThe magnitude and temporal dynamics of changes in blood nutrient and lipid levels following a high-fat meal have been previously shown to be an important indicator of current and future cardiovascular health and disease. Measurement of circulating nutrients and lipids currently requires invasive blood draws. The development of a non-invasive method for continuous monitoring of postprandial (i.e., after-meal) changes may assist in enhancing cardiovascular health management, dietary monitoring, and identification of disease-promoting factors. Spatial frequency domain imaging (SFDI) is a non-contact, label-free optical technique that can quantify tissue optical properties and hemodynamics in vivo. We hypothesized that SFDI may track the postprandial state in peripheral tissue.AimWe aim to investigate the relationship between postprandial factors, namely triglycerides and glucose, and the optical properties and oxygenation of peripheral tissue measured with SFDI.ApproachFifteen healthy volunteers consumed both a low- (2 g) and high- (60 g) fat meal on different days. A custom SFDI device was used to measure the dorsal hand surface of volunteers before the meal and each hour for 5 h after the meal. Measurements were taken at 730, 880, and 1100 nm. Longitudinal postprandial changes in tissue optical properties were correlated with changes in blood triglycerides and glucose levels as well as blood pressure, heart rate, and room temperature. A machine-learning model was trained to estimate triglyceride levels from SFDI metrics.ResultsSeveral SFDI metrics increased and peaked 3 to 4 h following the high-fat meal, including tissue oxygen saturation (StO2) and oxyhemoglobin (HbO2) concentration, and were substantially different from the low-fat cohort (p5% for StO2 and >10% for HbO2 concentration on average. The temporal changes in these metrics broadly tracked triglyceride levels, which peaked at 3 h post-meal. The predictive model accurately estimated blood triglyceride levels (RMSE 40 mg/dL).ConclusionThese findings suggest that SFDI could serve as a powerful non-invasive tool to monitor postprandial hemodynamics. In the future, SFDI measurements may help enhance cardiovascular disease prediction and management.